Lbmc Investment Advisors, LLC Bristol Myers Squibb CO Transaction History
Lbmc Investment Advisors, LLC
- $1.38 Billion
- Q2 2025
A detailed history of Lbmc Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lbmc Investment Advisors, LLC holds 6,980 shares of BMY stock, worth $320,731. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,980
Previous 7,880
11.42%
Holding current value
$320,731
Previous $480,000
32.71%
% of portfolio
0.02%
Previous 0.04%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.79 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...